Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN gastrointestinal disorder
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
UMSL hosts Greek community celebration of ‘KYKLOS – Circle of Glory’
The Hellenic Spirit Foundation pushed for the creation of the mural by St. Louis artist Rip Kastaris ahead of the 2004 Olympic Games, and it still hangs in the Olympic stadium in Athens.
MORE IN gastrointestinal disorder
LATEST NEWS
- UMSL hosts Greek community celebration of ‘KYKLOS – Circle of Glory’
- Associate Professor Carissa Philippi presents on understanding depression and trauma through the brain as part of NextGen Precision Health’s Discovery Series
- Newly renovated University Libraries ready to support students in their quest for knowledge and career success
- Opportunity Scholar Nadia Manushev pursues career in optometry through the Department of Biology’s 3+4 program
- At Greater St. Louis, Inc., UMSL alum Kylee Garretson attracts companies to invest in St. Louis
- UMSL’s Advanced Workforce Center delivers diverse pathways to prepare the workforce of tomorrow
- Eye on UMSL: Banging the drum for peace
- College of Nursing hosts escape room simulation focused on infection prevention training
- New NextGen Leaders program aims to prepare students to become changemakers in their communities
- UMSL Innovation Center celebrates official grand opening
